semaglutide for binge eating disorder The Ozempic Era and Disorders — Baltimore Therapy Group Glucagon-like peptide-1receptor agonists (GLP-1 RAs),

Some examples of the carrier-mediated transporters include the glucose carrier 1 (GLUT1), the LAT1/2, cationic amino acid transporter 1 and 3 (CAT1/3), the monocarboxylic acid carrier 1 and 8 (MCT1/8), the fatty acid transport protein 1 and 4 (FATP1/4), the sodium-independent concentrative nucleoside transporter-2 (CNT2), the organic cation transporter 2 (OCTN2), the OAT3, and the organic anion transporting peptides (OATP1C1, OATP1A4, OATP2B1) [12]

Zhang K, Wiedemann S, Dschietzig M, Cremers MM, Augstein A, Poitz DM, et al

Musso G, Gambino R, Cassader M (2010) Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded

doi:10.1371/journal.pmed.1004871 6

Discontinue promptly if suspected and avoid re-exposure to exenatide Serious Injection-Site Reactions (eg, abscess, cellulitis, and necrosis), with or without subcutaneous nodules, have been reported Acute Gallbladder Disease has been reported in GLP-1 receptor agonist trials, including exenatide